Endocrinology, Vol 134, 2072-2078, Copyright © 1994 by Endocrine Society

ARTICLES

Mechanisms of insulin resistance during acute endotoxemia

A Virkamaki and H Yki-Jarvinen
Second Department of Medicine, University of Helsinki, Finland.

We characterized the mechanisms underlying acute endotoxin-induced alterations in glucose metabolism and determined the extent to which catecholamines mediate these changes. Acute endotoxemia was induced in chronically catheterized awake rats by a bolus injection of lipopolysaccharide (LPS; 1 mg/kg; LD10). Basal glucose turnover (Rt; infusion of [5-3H]glucose), in vivo insulin action on overall glucose utilization (euglycemic clamp), glycolysis, and glycogen synthesis were determined in four groups of rats. These groups received 1) LPS (LPS rats; n = 6), 2) saline (control rats; n = 6), 3) LPS and alpha beta- blockade (alpha beta-blockade and LPS rats; n = 9), or 4) saline and alpha beta-blockade (alpha beta-blockade control rats; n = 9). In the basal state, LPS induced hypotension and transient hyperglycemia. These changes were associated with glycogen depletion in both skeletal muscle and liver, and increased Rt. During hyperinsulinemia, whole body glucose disposal was 37% decreased (105 vs. 166 mumol/kg.min; P < 0.01). This whole body insulin resistance was characterized by decreased glycogen synthesis and glycogen synthase activity, but not by altered whole body glycolysis. alpha beta-Blockade abolished transient hyperglycemia, increased Rt, and accelerated basal liver glycogen depletion (45 vs. 105 mmol/kg dry, LPS and alpha beta-blockade rats vs. LPS rats; P < 0.05), but inhibited muscle glycogenolysis. alpha beta- Blockade did not reverse the insulin resistance induced by endotoxin. These data suggest that catecholamines counteract the LPS-induced increase in basal glucose turnover and stimulate muscle glycogenolysis during acute endotoxemia. These effects might explain the better preservation of hepatic glycogen in the absence than in the presence of alpha beta-blockade and serve as a defense mechanism against hypoglycemia. Catecholamines do not seem to be the immediate causes of insulin resistance during acute endotoxemia.

This article has been cited by other articles:

				M. Membrez, F. Blancher, M. Jaquet, R. Bibiloni, P. D. Cani, R. G. Burcelin, I. Corthesy, K. Mace, and C. J. Chou Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice FASEB J, July 1, 2008; 22(7): 2416 - 2426. [Abstract] [Full Text] [PDF]

				J. I. Beier, L. Guo, C. von Montfort, J. P. Kaiser, S. Joshi-Barve, and G. E. Arteel New Role of Resistin in Lipopolysaccharide-Induced Liver Damage in Mice J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 801 - 808. [Abstract] [Full Text] [PDF]

				Y. Chen, D. Sun, V. M. R. Krishnamurthy, and R. Rabkin Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1856 - E1862. [Abstract] [Full Text] [PDF]

				C. L. Sherry, J. C. O'Connor, J. M. Kramer, and G. G. Freund Augmented Lipopolysaccharide-Induced TNF-{alpha} Production by Peritoneal Macrophages in Type 2 Diabetic Mice Is Dependent on Elevated Glucose and Requires p38 MAPK J. Immunol., January 15, 2007; 178(2): 663 - 670. [Abstract] [Full Text] [PDF]

				D. A. van Waardenburg, T. C. Jansen, G. D. Vos, and W. A. Buurman Hyperglycemia in Children with Meningococcal Sepsis and Septic Shock: The Relation between Plasma Levels of Insulin and Inflammatory Mediators J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3916 - 3921. [Abstract] [Full Text] [PDF]

				K. Ueki, T. Kondo, and C. R. Kahn Suppressor of Cytokine Signaling 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Receptor Substrate Proteins by Discrete Mechanisms Mol. Cell. Biol., June 15, 2004; 24(12): 5434 - 5446. [Abstract] [Full Text] [PDF]

				J.-P. Tessier, B. Thurner, E. Jungling, A. Luckhoff, and Y. Fischer Impairment of glucose metabolism in hearts from rats treated with endotoxin Cardiovasc Res, October 15, 2003; 60(1): 119 - 130. [Abstract] [Full Text] [PDF]

				S. Oguri, K. Motegi, Y. Iwakura, and Y. Endo Primary Role of Interleukin-1{alpha} and Interleukin-1{beta} in Lipopolysaccharide-Induced Hypoglycemia in Mice Clin. Vaccine Immunol., November 1, 2002; 9(6): 1307 - 1312. [Abstract] [Full Text] [PDF]

				A. O. Agwunobi, C. Reid, P. Maycock, R. A. Little, and G. L. Carlson Insulin Resistance and Substrate Utilization in Human Endotoxemia J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3770 - 3778. [Abstract] [Full Text]

				A. Virkamaki, M. C. Daniels, S. Hamalainen, T. Utriainen, D. McClain, and H. Yki-Jarvinen Activation of the Hexosamine Pathway by Glucosamine in Vivo Induces Insulin Resistance in Multiple Insulin Sensitive Tissues Endocrinology, June 1, 1997; 138(6): 2501 - 2507. [Abstract] [Full Text] [PDF]